Anaxomics is committed to the discovery and development of new and better drugs to improve human health. The main goal is to help the biopharma industry to maximize the value of their discovery and clinical development by leveraging the potential indications of all the compounds in their pipeline, and by identifying and minimizing their potential safety risks. Anaxomics is a client-focused company, with strong stress in quality and innovative approaches to solve current bottlenecks in drug discovery and clinical development.

This company has the infrastructure and equipment necessary to cover all tasks assigned in ITN-TREATMENT, including: secured IT facilities to manage confidential information, cluster-computing equipment, data-storage facilities, bioinformatics software (proprietary) and databases (proprietary).